Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2018

Sep 12, 2018

29745_dirs_2018-09-12_b8c8641c-2fc3-47d1-8a81-4c581ff76700.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Zymeworks Inc. (ZYME)
CIK: 0001403752
Period of Report: 2018-09-10

Reporting Person: LILLY ELI & CO (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-09-10 Common Stock S 4500 $14.44 Disposed 3915654 Direct
2018-09-11 Common Stock S 11277 $14.87 Disposed 3904377 Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $14.25 to $14.61. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: This transaction was executed in multiple trades at prices ranging from $14.29 to $15.29. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.